Two Sigma Investments Portfolio holdings
AUM
$55.5B
1-Year Return
27.18%
This Quarter Return
+6.41%
1 Year Return
+27.18%
3 Year Return
+82.36%
5 Year Return
+135.75%
10 Year Return
+365.6%
AUM
$33.8B
AUM Growth
+$2.77B
(+8.9%)
Cap. Flow
-$508M
Cap. Flow
% of AUM
-1.51%
Top 10 Holdings %
Top 10 Hldgs %
7.62%
Holding
3,303
New
580
Increased
1,075
Reduced
1,073
Closed
446
Top Buys
| 1 |
Ford
F
|
+$265M |
| 2 |
Netflix
NFLX
|
+$246M |
| 3 |
Walmart
WMT
|
+$240M |
| 4 |
Danaher
DHR
|
+$208M |
| 5 |
ConocoPhillips
COP
|
+$204M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
+$371M |
| 2 |
Tesla
TSLA
|
+$305M |
| 3 |
Salesforce
CRM
|
+$273M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$263M |
| 5 |
Airbnb
ABNB
|
+$261M |
Sector Composition
| 1 | Healthcare | 16.13% |
| 2 | Consumer Discretionary | 13.17% |
| 3 | Industrials | 12.69% |
| 4 | Technology | 12.66% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
BioRestorative Therapies
BRTX
$12.5M
| $57.9K | ﹤0.01% |
+17,026
| New | +$57.9K |
|
|
IPM
2627
Intelligent Protection Management Corp. Common Stock
IPM
$24.9M
| $57.1K | ﹤0.01% |
+26,791
| New | +$57.1K |
|
|
FLNT
2628
Fluent
FLNT
$48.1M
| $56.7K | ﹤0.01% |
11,523
-9,735
| -46% | -$47.9K |
|
2629
Dominari Holdings
DOMH
$103M
| $56.6K | ﹤0.01% |
17,579
-31,420
| -64% | -$101K |
|
2630
iHeartMedia
IHRT
$323M
| $56.2K | ﹤0.01% |
14,400
-2,800
| -16% | -$10.9K |
|
2631
Cognition Therapeutics
CGTX
$208M
| $55.9K | ﹤0.01% |
28,236
-18,384
| -39% | -$36.4K |
|
2632
Direct Digital Holdings
DRCT
$9.26M
| $55.9K | ﹤0.01% |
17,255
-15,772
| -48% | -$51.1K |
|
|
CMRX
2633
DELISTED
Chimerix, Inc.
CMRX
| $55.8K | ﹤0.01% |
44,298
-577,650
| -93% | -$728K |
|
|
GRTX
2634
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $55.8K | ﹤0.01% |
+21,791
| New | +$55.8K |
|
2635
Laser Photonics
LASE
$37.3M
| $54.8K | ﹤0.01% |
11,742
-34,722
| -75% | -$162K |
|
2636
Polestar Automotive Holding ADS Class C-1
PSNYW
$699M
| $54.7K | ﹤0.01% |
+65,800
| New | +$54.7K |
|
2637
Apyx Medical
APYX
$74.5M
| $54.1K | ﹤0.01% |
+18,800
| New | +$54.1K |
|
|
TCRR
2638
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $54K | ﹤0.01% |
36,000
-84,677
| -70% | -$127K |
|
2639
MEI Pharma
MEIP
$101M
| $53.5K | ﹤0.01% |
11,697
+2,477
| +27% | +$11.3K |
|
|
NEXN
2640
Nexxen International
NEXN
$606M
| $52.9K | ﹤0.01% |
+10,081
| New | +$52.9K |
|
|
SHCR
2641
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $52.7K | ﹤0.01% |
37,100
+22,900
| +161% | +$32.5K |
|
2642
Singularity Future Technology
SGLY
$4.54M
| $51.9K | ﹤0.01% |
7,627
-1,489
| -16% | -$10.1K |
|
2643
Tourmaline Bio
TRML
$1.22B
| $51.8K | ﹤0.01% |
2,756
-7,711
| -74% | -$145K |
|
2644
Lunai Bioworks Inc. Common Stock
RENB
$46.3M
| $51.4K | ﹤0.01% |
56,152
-33,515
| -37% | -$30.7K |
|
2645
OmniAb
OABI
$226M
| $50.4K | ﹤0.01% |
13,700
| – | – |
|
2646
bioAffinity Technologies
BIAF
$7.55M
| $50.2K | ﹤0.01% |
+26,587
| New | +$50.2K |
|
2647
Compass Therapeutics
CMPX
$606M
| $49.8K | ﹤0.01% |
+15,222
| New | +$49.8K |
|
2648
Aligos Therapeutics
ALGS
$74.4M
| $49.7K | ﹤0.01% |
2,274
-1,343
| -37% | -$29.3K |
|
2649
NeueHealth
NEUE
$60.8M
| $49.5K | ﹤0.01% |
2,809
+2,153
| +328% | +$37.9K |
|
2650
Cardiff Oncology
CRDF
$136M
| $49.5K | ﹤0.01% |
30,000
+6,691
| +29% | +$11K |
|